FXI

Clinical trials for FXI explained in plain language.

Never miss a new study

Get alerted when new FXI trials appear

Sign up with your email to follow new studies for FXI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a single injection silence a clotting protein and prevent strokes?

Disease control Ongoing

This trial tests an experimental drug called FXI-GalNAc-siRNA, which uses RNA technology to temporarily lower a clotting protein in the blood. The goal is to see if a single injection is safe and how the body processes it in healthy adults aged 18 to 55. If it works, this approac…

Matched conditions: FXI

Phase: PHASE1 • Sponsor: Sirnaomics • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC

FXI

Get alerted when new FXI trials appear

Can a single injection silence a clotting protein and prevent strokes?